GlassScriptPhysician profile
Jennifer Bell
NPI 1669247243
$1,523.92
in general payments reported to CMS, 2019-2025
20 companies · $951 in 2025
The $951 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $31.67 · 2024: $542 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,523.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $315.45 | 2023-2025 | |
| Novo Nordisk INC | $262.68 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $145.09 | 2024-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $129.44 | 2025 | Fanapt |
| Astrazeneca Pharmaceuticals LP | $79.39 | 2024-2025 | Airsupra, Farxiga |
| Phathom Pharmaceuticals, INC. | $79.18 | 2024 | Voquezna |
| Aimmune Therapeutics, INC. | $74.09 | 2024-2025 | Zenpep |
| Axsome Therapeutics, INC. | $73.25 | 2025 | Auvelity |
| Pfizer INC. | $64.89 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $58.30 | 2025 | Jornay Pm |
| Corium, LLC | $50.77 | 2024-2025 | Azstarys |
| Abiomed | $37.15 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $34.45 | 2025 | Abilify Maintena, Rexulti |
| Mylan Specialty L.P. | $29.24 | 2024 | Yupelri |
| Lundbeck LLC | $16.47 | 2025 | Rexulti |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.85 | 2025 | Jardiance |
| Lilly USA, LLC | $15.78 | 2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $14.88 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $14.31 | 2025 | Otezla, Repatha |
| Dexcom, INC. | $13.26 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.